Literature DB >> 15329421

Predicting Progression--ZAP-70 in CLL.

Terry J Hamblin1.   

Abstract

Mesh:

Substances:

Year:  2004        PMID: 15329421     DOI: 10.1056/NEJMp048184

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  4 in total

1.  ZAP-70 enhances IgM signaling independent of its kinase activity in chronic lymphocytic leukemia.

Authors:  Liguang Chen; Lang Huynh; John Apgar; Li Tang; Laura Rassenti; Arthur Weiss; Thomas J Kipps
Journal:  Blood       Date:  2007-11-29       Impact factor: 22.113

2.  B-cell-specific IRF4 deletion accelerates chronic lymphocytic leukemia development by enhanced tumor immune evasion.

Authors:  Daniela Asslaber; Yuan Qi; Nicole Maeding; Markus Steiner; Ursula Denk; Jan Philip Höpner; Tanja Nicole Hartmann; Nadja Zaborsky; Richard Greil; Alexander Egle
Journal:  Blood       Date:  2019-11-14       Impact factor: 22.113

Review 3.  Best Practice No 185. Cytological and molecular diagnosis of lymphoma.

Authors:  G Kocjan
Journal:  J Clin Pathol       Date:  2005-06       Impact factor: 3.411

4.  Tebrophen--an old polyphenol drug with anticancer potential.

Authors:  Ivica Rubelj; Višnja Stepanić; Dubravko Jelić; Nikolina Škrobot Vidaček; Andrea Ćukušić Kalajžić; Milena Ivanković; Krunoslav Nujić; Mario Matijašić; Donatella Verbanac
Journal:  Molecules       Date:  2012-06-28       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.